治疗干燥的与年龄相关的黄斑变性:我们在2024年站在哪里
Sydney Wheeler1, Raziyeh Mahmoudzadeh2, Jessica Randolph2
1Virginia Commonwealth University School of Medicine.
Current opinion in ophthalmology
|June 13, 2024
概括
现在有新的治疗方法可用于高级干燥与年龄相关的黄斑变性 (AMD),特别是地理缩 (GA). 对早期干预措施的研究正在进行中,为AMD患者改善视力结果提供了希望.
科学领域:
- 眼科医生 眼科 眼科
- 视网膜疾病 视网膜疾病
- 医学研究 医学研究
背景情况:
- 与地理缩 (GA) 相关的干老黄斑变性 (AMD) 是全球视力丧失的主要原因.
- 在此之前,没有任何治疗方法被批准用于GA,影响全球数百万人.
研究的目的:
- 审查干燥AMD的当前和研究中的治疗选择.
- 要总结最近的临床研究和治疗干性AMD的进展.
主要方法:
- 现有治疗方法和正在进行的临床试验的文献综述.
- 对治疗方法的分析,包括补充抑制,基因疗法和干细胞疗法.
主要成果:
- 现在美国FDA批准了两种GA治疗方法.
- 多项研究正在探索治疗干性AMD早期阶段的疗法.
- 研究性疗法包括补充系统抑制剂,基因疗法,干细胞疗法,激光疗法和外科植入物.
结论:
- 首次,FDA批准的治疗方法存在于地理缩 (GA),这是高级干燥AMD的一种形式.
- 从干性AMD的临床研究中,有前途的医疗和手术管理策略正在出现.
- 在治疗干性AMD方面取得了显著进展,补充了湿性AMD疗法的进步.
更多相关视频
10:14Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
3.1K
07:04Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
Published on: February 4, 2021
2.0K
相关概念视频
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Open Angle Glaucoma: Treatment
427
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
427
